Literature DB >> 19502209

Economic and clinical impact of inpatient diabetic hypoglycemia.

Suellen M Curkendall1, Jaime L Natoli, Charles M Alexander, Brian H Nathanson, Tracy Haidar, Robert W Dubois.   

Abstract

OBJECTIVE: To assess the clinical and economic impact of hypoglycemia that develops during hospitalization of patients with diabetes.
METHODS: In this retrospective cohort study, data from 70 hospitals were used to identify the first inpatient encounter for adult patients with diabetes. Patients were included if all blood glucose measurements were 70 mg/dL or higher during the first 24 hours and their primary discharge diagnosis was for a condition other than hypoglycemia. Those who developed laboratory evidence of hypoglycemia (blood glucose <70 mg/dL after 24 hours) were compared with patients whose blood glucose values were all 70 mg/dL or higher. An alternative definition of hypoglycemia (blood glucose <50 mg/dL after 24 hours) was also evaluated. We adjusted for potential confounders with multivariate models.
RESULTS: Hypoglycemia had an adverse effect on all outcomes among more than 100,000 diabetic patients. After adjustment, patients with diabetes who developed hypoglycemia had higher charges (38.9%), longer lengths of stay (3.0 days), higher mortality (odds ratio, 1.07; 95% confidence interval, 1.02-1.11), and higher odds of being discharged to a skilled nursing facility (odds ratio, 1.58; 95% confidence interval, 1.48-1.69) than diabetic patients without hypoglycemia (P<.01 for all). In all cases, using the lower threshold (<50 mg/dL) to define hypoglycemia resulted in similar findings with a larger magnitude of differences.
CONCLUSIONS: Although a direct causal relationship cannot be inferred, these study findings suggest the importance of carefully maintaining euglycemia during hospitalizations. Whether the observed worse outcomes were due to hypoglycemia itself or whether they were a marker of worse outcomes due to other causes requires further research.

Entities:  

Mesh:

Year:  2009        PMID: 19502209     DOI: 10.4158/EP08343.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  24 in total

1.  Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.

Authors:  Carmelo Graffagnino; Ananda R Gurram; Bradley Kolls; DaiWai M Olson
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 2.  Designing the Glucose Telemetry for Hospital Management: From Bedside to the Nursing Station.

Authors:  Medha Satyarengga; Tariq Siddiqui; Elias K Spanakis
Journal:  Curr Diab Rep       Date:  2018-08-29       Impact factor: 4.810

3.  Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study.

Authors:  Lakshmi G Singh; David L Levitt; Medha Satyarengga; Lillian Pinault; Min Zhan; John D Sorkin; Jeffrey C Fink; Guillermo E Umpierrez; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2019-11-28

Review 4.  How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting.

Authors:  Kristen Kulasa; Patricia Juang
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

5.  Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients.

Authors:  Quyen N Bach; Rod A Gilmore; Melody C Sheffield; W Anthony Hawkins
Journal:  Hosp Pharm       Date:  2017-10-12

6.  Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.

Authors:  David L Levitt; Elias K Spanakis; Kathleen A Ryan; Kristi D Silver
Journal:  Diabetes Technol Ther       Date:  2018-01-02       Impact factor: 6.118

7.  Advancing the Use of CGM Devices in a Non-ICU Setting.

Authors:  Meng Wang; Lakshmi G Singh; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2019-01-13

Review 8.  The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes.

Authors:  Sherita Hill Golden; Nisa Maruthur; Nestoras Mathioudakis; Elias Spanakis; Daniel Rubin; Mihail Zilbermint; Felicia Hill-Briggs
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

Review 9.  Impact of hypoglycemia in hospitalized patients.

Authors:  Michelle Carey; Laura Boucai; Joel Zonszein
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

Review 10.  Hyperglycemia and Acute Kidney Injury During the Perioperative Period.

Authors:  Carlos E Mendez; Paul J Der Mesropian; Roy O Mathew; Barbara Slawski
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.